VP, Prin. Accounting Officer · Cue Biopharma, Inc. · Common Stock
Side
SELL
Value
$93.39
Shares
3
Price
$31.13
Executed
Aug 13, 2026
Disclosed
Aug 17, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Aug 13 executedAug 17, 2026 disclosed
CUE · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Meluzio Michael Vincent filed this Form 4 reporting a open-market sale of CUE on Aug 13, 2026. It became public on Aug 17, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
VP, Prin. Accounting Officer
Meluzio Michael Vincentcik:0002138368
Issuer
Cue Biopharma, Inc.cik:0001645460
Revision history · 0
No field has changed since this record was first ingested.
